PIN1 and cancer: However, because the available Pin1 inhibitors lacked the required specificity and/or potency, or cannot enter cells19, 20, 21, it was challenging to evaluate the significance of targeting Pin1 for cancer treatment until our discovery of all-trans retinoic acid (ATRA) as a Pin1 inhibitor22.